L'Aquila, Italy

Stefano Porzio

This inventor holds 2 USPTO granted patents. Top assignee: Dompe S.p.a.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefano Porzio. Retrieved from https://idiyas.com/inventor/stefano-porzio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Stefano Porzio

Introduction

Stefano Porzio is an accomplished inventor based in L'Aquila, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address tissue damage caused by inflammation. With a total of 2 patents to his name, Porzio's work is recognized for its potential impact on medical treatments.

Latest Patents

Porzio's latest patents include the invention of N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them. These compounds are designed to be useful in the prevention and treatment of tissue damage due to exacerbated recruitment of polymorphonuclear neutrophils (PMN leukocytes) at inflammatory sites. The innovative nature of these compounds highlights Porzio's commitment to advancing medical science.

Career Highlights

Throughout his career, Porzio has worked with notable companies, including Dompe S.p.a. His experience in the pharmaceutical industry has allowed him to develop and refine his inventions, contributing to advancements in healthcare.

Collaborations

Stefano Porzio has collaborated with esteemed colleagues such as Riccardo Bertini and Cinzia Bizzarri. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Stefano Porzio's contributions to the field of pharmaceuticals through his patents and collaborations demonstrate his dedication to improving medical treatments. His work continues to inspire advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…